Answers are grounded in this paper and cite their sources.
Measuring gene activity in individual cells reveals the diversity within tumors but is costly, technically noisy, and often captures too few rare cells. Computer-generated cells could fill these gaps. Here we show, across two independent groups of pancreatic cancer patients, that a deep generative model produces realistic synthetic cells. Explicitly modeling correlations within the model’s compressed description of each cell does not improve preservation of gene-gene relationships over a simpler matched model, which appears to capture this structure implicitly. Nevertheless, the model’s sampling strategy yields cells that faithfully reproduce gene activity patterns, cell-type markers, and cellular organization and compare favorably with established methods. The model trains 100 to 1,000 times faster than a diffusion-based alternative. Synthetic cells blend with real data and support standard analyses, including reconstruction of a precancerous transition. These findings support using synthetic cells to enrich rare populations, benchmark methods, and simulate transitional states in tumors.
No takes yet. Share an insight, caveat, or question.
Redondo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: